Advertisement
Advertisement
LGND
Ligand Pharmaceuticals Inc.
231.82
USDSponsored
+8.58
+3.84%
Apr 17, 16:00 UTC -4
Closed
After-Market
231.99
+0.17
+0.07%
Ligand Pharmaceuticals Inc. Financial Snapshot
| Market Cap | 4.63B |
| Beta | 1.14 |
| Earnings Per Share (EPS) | 5.83 |
| Price-to-Book (P/B) Ratio | 3.98 |
| Operating Margin | 46.42% |
| Total Debt/Equity (D/E) | 43.86% |
| P/E Ratio | 35.27 |
| Return on Equity (ROE) | 13.86% |
| Current Ratio | 22.23% |
| Free Cash Flow | 38.05M |
Trending Stocks
Advertisement